Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

salmonella Mo.B.1217, lh.1.428 I,Tu.B.2 192 saquinavir Mo.A. 1056, Mo.B. 1139, No.B. 1206, MNo. B.172, M o. B.4 1 0, Th.B8.4225, TTh.B.4335, Th.B.4348, Th.B.4349, Tu. B.2 12 3,-Tu. B.2 I124, Tu. B.22 I17, Tu.B8.520, Tu.B.542, We.B.3 I135 scenario analysis MoC. 1572, MoC. 1575, MoC. 1579, Pub.C. 1161, Th.C.200, Th.C.44 19, Th.C.4606,Th.D.4968,Th.D.50 19, Th.D.502 I,Tu.C.203,Tu.D.252,Tu.D.253, Tu.D.2862 schools No.B.553, No.D. I 723, MoD. 1730, Mo.D.244, Pub.C. I1194, Pub.D. 1 357, Pub.D. I1370, Pub.D. I1371, Pub.D. I1372, Pub.D. 1373, Pub.D. I1374, Pub.D. 1432, Th.C.4376, Th.C.4403, Th.C.44 15, Th.C.44 I18, Th.C.44 19, Th.C.4424, Th.C.4426,Th.C.4427,Th.C.443 I, Th.C.4438, Th.C.4442, Th.D. I136, Th.D.487 I,Tu.C.21I4,Uui.C.330,Tu.C.334, Tu.D.2792,Tu.D.2793,Tu.D.2795, Tu.D.2797, Tu.D.2798, Tu.D.2807, Tu.D.2808,Th.D.2809,Tu.28 I13, Tu.D.28 I 6,Tu.[).28 I 8,Tu.D.282 I, Tu.D.2835,To.D.29 I I, We.C.203, We.D3742, We.D.3 747, We.D.379 1, We.D.3797 screening Mo.A. 1020, Mo.A. 1062, Mo.A. 1063, Mo.B. I1147, No.8.1 186, MoC. 1458, Mo.C. 15 17, MoC. I1534, Mo.C. I1602, Mo.C.2 I1I, Mo.D. 1724, Pub.B. 1047, Pub.C. II111, Pub.C. 11I55, Pub.C.I I 176, Pub.C. 11I78, Pub.C. 1 21I6, Pub.C. I124 1, Th.A.4003,Th.A.4046,Th.B.4 I150, Th.B.4 I 55,Th.B.4 190,1 h.B.4259, Th.C.4404, Th.C.4450, Th.C.4592, Th.C.4593;Efh.C.4596, Th.c.4599, Th.C.4605, T i.C.46 I13, Th.C.465 1, Th.C.4750, Tb.D.4983, Tu.A. 105, Tu.A.2020,1U. B. 2.162, Tu.B.2 166, Tu.B.2292, lu.C,2462, Tu.C.247 7, We.B.542, We.C.2 I I, We.C.343 7, We.C.3573, We.C.3590, We.D.3607 seborrheic dermatitis M o. B. I1277, M o.B. 1279 selective agent No.A. 1 057, Mo.A. 1095, We.A.30 14 selenium Mo.B. I 395,Th.C.445 1, We.B. 182, We.B.3258, We.B.326 I, We.B.3267 self antigens Mo.A.282, We.A.3040 self identification molecules Th.D. I33 self-help Mo.B. 1 153, Mo.B. 11I67, Mo.D. 1765, Mo.D. 1774, Mo.D. 1861, Mo.D. 1885, Mo.D. 1945, Mo.D.24 1, Pub.D. 1 376, Pub.D. 1460, Pub.D. 1473, Pub.D. 1491, Pub.D. 1492, Pub..1493, Pub.D. I1494, Th.C.4562,Th.D. 12,32,Th.D. I 34,Th.D.250, Th.D.4870,Th.D.5046, Th.D.5 108, seminal fluid Mo.A. I 083,Th.C.44 7 I, Tu.B.2243, Tu.C.269 I, We.B.3383, We.C.335, We.C.3506, We.C.35 I14, We.C.3522 sensitivity of tests Mo.A. 160, Mo.B. 1229, Mo.C. 1528, Pub.B. 1043, Pub.C. 115 5, Th.A.4023, Th.A.4026, Th.A.4032, Th.A.4035, Th. B.4 I197, Tu.A. 15 3, Tu.B.5 22, We. B. 3178 septicemia, SEE also specific organisms Mo.B. 121 1, Mo.B. 121 5, 1h.B.428 1, Tu.B.2 181,Tu.B.2365, We.B.3204, We.B.3205,We.B.32 I10, We.B.33 18 seroconversion No.8. I1I5 I, Mo.B. I I76, No.B. 11I84, Mo.B. I 185, No.8. 1336, No.8.1341, Mo.C. 1555, Mo.C.57 1, MoD. I1 11, Mo.D. 1745, Mo.[).1I756, Pub.C. I1104, Pub.C.l 123, Pub.C.l 141,Tb.A.274, Th.B.4 I 53,Th.B.4 I157,11.0.4350, Th.C.342,Th.C.438 I,1 h.C.4404, Tu.A. I 53, To.A.20 I16, Tu.A.2 I108, lo.A.5 I12, Tu.B.2 I 67,Tui.B.2 I169, lu,.C.2388, T.C.2390,Tu.C.2430,-ij.C.2435, Tu.C.2498,Tu.C.258 3, l u.C.2658, Th.C.43 I,Tu.D.2746,Tu.D.292 1, We.A.300 I, WeJ3.3167/, We.B.3 170, We.B.3 175, We.B.3 178, We.B.3254, We.B.335 I, We.B.530, We.B.53 1, We.B.532, We.C.3542, We.D.3655 serodiagnosis Mo.A.5 I 1, Mo.A.5 12, No.3. I1/6, No.8.1 178, No.8.1 179, No.8. 1182, No.B. I1I84, No.8. I1I85, No.8. 11I86, No.C. 1449, Mo.C. I450, No.C. 1470, Mo.C. 1999, Mo.C. 1507, Mo.C. 1 53 1, Mo.C. 15 34, Mo.C. 15 37, Pub.A. 1007, Pob.B. 104 1, Pub.B. 1043, Pub.C. 1247, Th.A.4003, Th.A.40 I12, hAlO I16, T b.A.40 I17, Th.A.4023, 'Vh.A.4026, Th.A.4049,Th.B.4 I 53,Tb.B 4156, Th.B.4 I157,-Th.B.4 160, Yh.C.463 1, Tu.A. I15 I, Tu.A. I 5 3, Tu.A.2005, 3u.B.2 174, Tu.C.223, We.A.30 I16, We.A.30 18, We.A.3020, We.A.301 I, Wo.B.3 167, We.B.3 170, We.B.3 171, We.B.3 I172, We.B.3 I179, We.B.3 185 seroepidemiology No.C. 14 I13, NoC. 1433, No.C. 1438, No.C. 1445, NoC. 1465, NoC. 1475, No.C. 1480, No.C. 1483, No.C. 1489, No.C. 1510, NoC. 1526, NoC. 154 6, No.C. 1567, No.C.333, No.C.464, Pub.C. I1156, Pob.D. 1 328, Th.C.4366, Th.D.440, Tu.A. I105, Tu.A.2070, Th.C.22 I, Tu.C.243 I,Tu.C.2462, Ji.C.2480, Tu.C.2493,Tu.C.2535,Tu.C.2607, Tu.C.265 I,Tu.C.560, We.8.3 192, We.C.345 seroincidence No.A.5 12, No.B. 1234, MoC. 123, No.C. 1445, NoC. 1450, NoC. 1466, NoC. 1480, No.C. 1483, NoC. 1672, Mo.C.442, Pub.C.I 1119, Th.A.162, Th.C.222,Th.C.342, u.A.2030, Tu.C.2409,Tu.C.24 I18, Tu.C.2449, Iu.C.2527,Tu.C.2620, Toa.C.2653, 1 h.B.4 I 54,Tu.B.2 I162, We.B.3 171, We.B.3 I172, We.C.3426 seronegativity PLJLC. I I85,Th.A.4049,3 b.L.5020, lu.B.2 I68,Tu.C.2565,Tu.D.2956, We.A.300 I, We.A.3037, We.B.335 I seroprevalence No.C. 120, Ne.C. 1408, No.C. 1421, No.C. 144 1, No.C.1449, No.C.1453, MoC.1465, No.C. 1477, No.C. 1488, Mo.C. 1490, No.C. 1499, No.C. 1510, MoC. 1519, MoC. 1564, No.C. 1589, No.C. 1623, MoC. 1654, No.C. 1666, No.C.33 1, No.C.453, Mo.C.454, Pub.B.1091, Pub.B.1092, Pub.C.l1100, Pob.C.l1122, Pub.C.l1133, Pub.C.l1146, Pub.C. 1 159, Pub.C. I I78,Th.C.4366, Th.C.4404,Th.C.4600,Th.C.4609, 1Th.C.46 I 6,Th.C.4628,Th.C.4748, T h.D.360,-i i.A.3 74, T.C.200,Tu.C.225, Tu.C.2422, ii,.C.2482,Tu.C.2493, lu.C.2537, Iu.C.2538,T1u.C.255 1, Tu.C.2552, Th.C.2558, Thi.C.2620, Iu.C.265 I,Tu.C.2655,-3o.C.560,Tu.C.5/0, We.8.303, We.8.3141,We.D.233 seroreversion Ma.C. I1589,iTh.B.4 I II, bA. 374, We.B.3 175, Wo.B.3328 serotonin NoD. 1884 serum, blood No.B. 1329,1TTY A.1034, u.A.2035, 1 uB. 11I5, 1u.B.2305, We.B.3 I178 service utilisation No.8.116 1, No.8.1 17.3, No.8.1 84, NoD. I1758, No. 1906, PLub.C. I1I53, Piub.C. 1280, Pub.D. 10 360,Th.B. I194, Tb.[.4920,Tbh.D.5068, Th.D.5 I54, 1 611.51 84,Th.D.5 I186, Th.D.5 192, Tu.B.2 I 57,Tu,8.2 I160, We.C.3404, W/e.L.3694, We.D.3 71II,We.D.37 I5 sex (gender) NoD11. I686, PoL.D. I 324,Th.D.25 7, Th.D.443,To.C.254 1, T.C.2546, We.B.323 I, We.C.3392, We.C.3404, We.D.3757 sex workers No.C. 1487, Ma.C. 1666, No.C.44 I, No..1728, No.1). 1732, MoD. 1775, No.DIBS85, No.D.19 10, Mo.D.602, PLub.B. 1048, Pub.C. I1125, Pub.C. 11I47, Ptib.C. I1148, Pub.C. I1200, Pub.C. 1235, PuL.C. 1255, Pub.C. I1265, Pob.C. I1266, Pub.C. 1270, Pub.D. I1406, Pob..1469, 1 b-.C.4 32,Th.C.435,Th.C.4360, Th.C.4496, Th.C.4498,-Th.C.4638, 1 h.C.4644,Th.C.472 I,Th.C.4752, T1).C.181I8, 1i.C.4832, I h.D.463, TI.D.464,Th.D.466,1h.D.503 1, Th.D.5032,Th.D.5034,Th.D.5040, Th.D.5042,Th.D.5044,Th.D.505 I, 1h.[1.5054, Th.D.5055, Th.D.5058, u.C.2622, Tu.C.2635, Tu.C.2637, lu.C.2638, T.C.2642,Tu.C.2646, Tu.C.2653,Tu.C.2660,T[u.C.266 1, lu.C.2669, 1.C.455,Tu.D. I 36,Tu.D.46 1, We.C.226, We.C.332, We.D.3846, We.D.495 sex workers, clients sex workers, men Pnib.C. I I65,Th.C.460, lh.D.5038, Th.D.5043, To.C.2403, Tu.C.24 12, We.C.56 I sex workers, other Th.D.5032, We.D.485 sex workers, prevalence No.C. 1432, No.C. 1488, Ma.C. 1490, No.C.44 1, Mo.C.455,Th.C.4684, Th.C.4743,Th.D.5039,Tu.C.2637, Tu.C.2654,Tu.C.2672,Tu.C.2673, Ju.C.2684 sex workers, prevention No.C.44 1, Mo.D. 1795, Mo.D. 1795, No. 3185 1, Mo.D. 1864, Mo.D. 1940, Mo.D.602, Pub.B. 1046, Pub.C. 1 143, Pob.D. 1444, Th.C.32 I,Th.C.4497, 1 h.C.4640, T.C.4648, 1 h.C.4660, Th.C.467 I, ib.C.46/5, Th.C.4743, Th.C.4745,ThvL).24 I,Th.D.242,Th.E).462, I hvD464,Tbh.D.5030, ]i.D.5033, Vh.D.5034, Th.D.5037, Th.L.5038, Ti hD.5049,Th.D.5050,Th.D.5052, ]TvI1.5054, 1h.D.5058,Tu.C.26 IS, Yoi.C.2624,Tu.C.263 I,T.C.2635, 1iu.C.2659,To.C.266 I,Ju.D.240, Fu.D.2766,Tou.D.2905, We.C.3526, We.C.3602, We.D.233, We.D.3768, We.D.485 sex workers, SEE condoms Pub.C. I1220, Eh.C.4600, Th.C.4684, 1 h.D.464,Th.D.5045,Th.C.2673 sex workers, women No.8.1260, No.C. 1438, No.C. 1475, No.C. 1638, Ma.C. 1669, Mo.C.22 1, No.C.223, No.C.440, No.C.44 I, No.D. 1747, Mo.D. 1857, No.D. 1864, No.D.580, Pub.C. 1206, Pob.C. 1216, Pub.C. 1262, Pub.D. 1404, Th.A. 146, Th.C.323, Th.C.4637,Th.C.4749, 1 h.C.484 I, Th.D.242, Th.L.46 I, 16.11.463, ih.D.464, Th.D.465, Th.[).5034, 1 h.D.5035, Th.[).5039, T h.D.504 1, T1-i.D.5048, Eh.D.5058,Th.C.247 7, lu.C.2485, Tu.C.26 I17, To.C.26 I18, 3u.C.2634,3u.C.263 7, Io.C.2639, Tu.C.2648, Tu.C.2 654, Tu. C.2666, Vu.C.2670, 1.C.2672,Tu.C.2692, Tu.C.56 I,Ti.D.2945, We.C.3509, We.C.35 I10, We.D.3706, We.D.3787 sexual behaviour, analysis of risks No.C.1410, No.C. 1441, Mo.C.1442, No.C. 1450, No.C. 1472, No.C. 1509, No.C. 151 1, No.C.570, No.D. 1684, Mo.D.1685, No.D. 1687, No.D. 1690, Mo.D. 1692, No.D. 1693, No.D. 1694, No.D. 1695, Mo.D. 1701, No.D. 1708, M o. D.1709, MNo. D.17 16, M o.D. 1717, No.D. 1719, No.D. 1729, No.D,1730, No.D. 1731, MoD. 1732, No.D. 1734, No.D. 1736, No.D. 1780, No.D. 1821, No.D. 1851, No.D.354, No.D.49 I, Pub.C.lI l0I, Pub.C.l1126, Pub.C. 1146, Pub.C. 1149, Pub.C. 1199, Pub.C. 1210, Pob.C. 1229, Pub.D. 1292, Pub.D. 1294, Pujb.D. 1295, Pub.D. 13 17, Pub.D. 131 8, Pub.D. I1330, Pub.D. I1360, Pub.D. I1367, We.B.3235, We.C.220, We.C.35 13, We.C.35 I19, We.C.3520, We.C.44 1, We.C.562, We.D.3663, We.D.3676 ~0 v' U C b 0 U C Q) U c 0 O C a) C 498

/ 516
Pages

Actions

file_download Download Options Download this page PDF - Pages 491- Image - Page 498 Plain Text - Page 498

About this Item

Title
Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]
Author
International AIDS Society
Canvas
Page 498 - Comprehensive Index
Publication
1996
Subject terms
abstracts (summaries)
Item type:
abstracts (summaries)

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0110.046
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0110.046/508

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0110.046

Cite this Item

Full citation
"Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0110.046. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel